LSTA — Lisata Therapeutics Share News
0.000.00%
Last trade - 00:00- $10.91m
- $0.22m
- $0.17m
Brief: Lisata Therapeutics Q3 EPS USD -0.49
Brief: Lisata Therapeutics And Catalent Announce Global Antibody-Drug Conjugate License Agreement
Brief: Lisata Therapeutics Announces Encouraging Preliminary Results From The Pancreatic Cancer Cohort
TotalEnergies CEO says NextDecade to announce FID on Rio Grande LNG train on Tuesday, CNBC reports (updated)
Lisata Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
TotalEnergies won't invest in NextDecade’s Train 5 LNG project, sources say
Lisata Therapeutics Inc expected to post a loss of 65 cents a share - Earnings Preview
Lisata Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Lisata Therapeutics Inc expected to post a loss of 53 cents a share - Earnings Preview
Motor racing-Norris leads McLaren practice one-two as Tsunoda crashes (updated)
Brief: Lisata Therapeutics- Will Evaluate Efficacy Of Certepetide
Lisata Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Lisata Therapeutics Inc expected to post a loss of 76 cents a share - Earnings Preview
Lisata Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Lisata Therapeutics Inc expected to post a loss of 75 cents a share - Earnings Preview
Brief: Lisata Therapeutics And Valo Therapeutics Announce Preclinical Research Collaboration
Lisata Therapeutics Inc expected to post a loss of 75 cents a share - Earnings Preview
Lisata Therapeutics Inc expected to post a loss of 77 cents a share - Earnings Preview
Brief: Lisata Therapeutics Announces Sponsored Preclinical Research Agreement With The University Of Cincinnati To Study Certepetide For The Treatment Of Endometriosis